Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs

Core Insights - Everest Medicines, a biopharmaceutical company, is focused on discovering, developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines, particularly in the mRNA therapeutic vaccine space [1][6][7] Conference Call Details - The English session of the conference call is scheduled for 9:00 PM Beijing Time on March 6, 2025, which corresponds to 8:00 AM U.S. Eastern Time on the same day [2][3] - The Mandarin session will take place at 9:00 AM Beijing Time on March 7, 2025, equivalent to 8:00 PM U.S. Eastern Time on March 6 [4] - Access to the conference calls can be made through provided links and dial-in information for various regions, including the United States, Chinese Mainland, Hong Kong, and the United Kingdom [3][5] Company Overview - Everest Medicines aims to address critical unmet medical needs in Asian markets, with a management team that possesses extensive expertise from both global and local pharmaceutical companies [6][7] - The company has developed a portfolio of potentially global first-in-class or best-in-class molecules targeting renal diseases, infectious diseases, and autoimmune disorders [7]